Abstract:Vaccines play a critical role in combating infectious diseases and cancers, yet improving their efficacy remains challenging. Here, we introduce a separable nanocomposite hydrogel microneedle (NHMN) patch designed for intradermal and sustained delivery of ovalbumin (OVA), a model antigen, to enhance adaptive immune responses. The NHMN patch consists of an array of OVA-loaded microneedles made from photo-cross-linked methacrylated hyaluronic acid and laponite (LAP), supported by a hyaluronic acid backing. The incorporation of LAP not only enhances the mechanical strength of the pure hydrogel microneedles but also significantly prolongs OVA release. Furthermore, in vitro cell experiments demonstrate that NHMNs effectively activate dendritic cells without compromising cell viability. Upon skin penetration, NHMNs detach from the backing as the hyaluronic acid rapidly dissolves upon contact with the skin interstitial fluid, thereby acting as antigen reservoirs to release antigens to abundant skin dendritic cells. NHMNs containing 0.5% w/v LAP achieved a 15-day OVA release in vivo. Immunization studies demonstrate that the intradermal and sustained release of OVA via NHMNs elicited stronger and longer-lasting adaptive immune responses compared to conventional bolus injection. Given its easy to use, painless and minimally invasive features, the NHMN patch shows promise in improving vaccination accessibility and efficacy against a range of diseases. Statement of significance The study introduces a separable nanocomposite hydrogel microneedle (NHMN) patch. This patch consists of an array of ovalbumin (OVA, a model antigen)-loaded microneedles made from photo-cross-linked methacrylated hyaluronic acid and laponite, with a hyaluronic acid backing, designed for intradermal and sustained delivery of antigens. This patch addresses several key challenges in traditional vaccination methods, including poor antigen uptake and presentation, and rapid systematic clearance. The incorporation of laponite enhances mechanical strength of microneedles, promotes dendritic cell activation, and significantly slows down antigen release. NHMN-based vaccination elicits stronger and longer-lasting adaptive immune responses compared to conventional bolus injection. This NHMN patch holds great potential for improving the efficacy, accessibility, and patient comfort of vaccinations against a range of diseases.

Evolution of microneedle applicators for vaccination: the role of the latch applicator in optimizing dissolving microneedle-based immunization

Microneedles: quick and easy delivery methods of vaccines

Microneedle-Mediated Vaccination: Innovation and Translation.

Microneedle System for Transdermal Drug and Vaccine Delivery: Devices, Safety, and Prospects

Delivery systems for intradermal vaccination

Microneedle Patches as Drug and Vaccine Delivery Platform

Engineering microscopic delivery systems: a review of dissolving microneedle design, fabrication, and function

Intradermal Vaccination with PLGA Nanoparticles via Dissolving Microneedles and Classical Injection Needles

Microneedles: An Emerging Vaccine Delivery Tool and a Prospective Solution to the Challenges of SARS-CoV-2 Mass Vaccination

Structural design strategies of microneedle-based vaccines for transdermal immunity augmentation

Dissolving Microneedles Drug Delivery System: A Comprehensive Review

Egg microneedles for transdermal vaccination of inactivated influenza virus

Separable nanocomposite hydrogel microneedles for intradermal and sustained delivery of antigens to enhance adaptive immune responses

Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin

Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination

Enhanced immunity in intradermal vaccination by novel hollow microneedles

Microneedle technology for potential SARS-CoV-2 vaccine delivery

Enhanced Cancer Vaccination by In Situ Nanomicelle-Generating Dissolving Microneedles

Exploiting Unique Features of Microneedles to Modulate Immunity

Cyclodextrin microneedles for the delivery of a nanoparticle-based peptide antigen vaccine

Liposome-loaded Dissolvable Microneedle Patches for More Efficient Intradermal Antigen Delivery of Hepatitis B Vaccine